Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH) today announces that it will be present at four upcoming investor conferences in Q1 2017, where Innate Pharma’s management team, including Mondher Mahjoubi, the newly appointed Chief Executive Officer and Chairman of Innate Pharma’s Executive Board, will provide an overview of the Company.
The four investor conferences in Q1 2017 are:
- Oddo Midcap Forum – Lyon, France, January 5-6
- J.P. Morgan 35th Annual Healthcare Conference – San Francisco, CA, USA, January 9-12
- Leerink Partners 6th Annual Global Healthcare Conference – New York, NY, USA, February 15-16
- Credit Suisse London One on One Global Healthcare Conference – London, UK, February 28-March 1
Innate Pharma is committed to meet on a regular basis with the financial community. All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the Investors’ section (http://www.innate-pharma.com/en/investors).